Journal article Open Access

DESIGN & MOLECULAR DOCKING STUDIES OF COUMARIN SUBSTITUTED 1, 3, 4-OXADIAZOLES AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS.

Purohit S.S.*, Kulkarni V.H., Joshi S.D.


JSON Export

{
  "files": [
    {
      "links": {
        "self": "https://zenodo.org/api/files/ee59913b-cd13-48bf-b8d8-53f546eb2ec3/200306%20ready.pdf"
      }, 
      "checksum": "md5:57ad36da09b36fc637f588d4eeaf6822", 
      "bucket": "ee59913b-cd13-48bf-b8d8-53f546eb2ec3", 
      "key": "200306 ready.pdf", 
      "type": "pdf", 
      "size": 1589412
    }
  ], 
  "owners": [
    35756
  ], 
  "doi": "10.5281/zenodo.3864857", 
  "stats": {
    "version_unique_downloads": 22.0, 
    "unique_views": 41.0, 
    "views": 50.0, 
    "version_views": 50.0, 
    "unique_downloads": 22.0, 
    "version_unique_views": 41.0, 
    "volume": 38145888.0, 
    "version_downloads": 24.0, 
    "downloads": 24.0, 
    "version_volume": 38145888.0
  }, 
  "links": {
    "doi": "https://doi.org/10.5281/zenodo.3864857", 
    "conceptdoi": "https://doi.org/10.5281/zenodo.3864856", 
    "bucket": "https://zenodo.org/api/files/ee59913b-cd13-48bf-b8d8-53f546eb2ec3", 
    "conceptbadge": "https://zenodo.org/badge/doi/10.5281/zenodo.3864856.svg", 
    "html": "https://zenodo.org/record/3864857", 
    "latest_html": "https://zenodo.org/record/3864857", 
    "badge": "https://zenodo.org/badge/doi/10.5281/zenodo.3864857.svg", 
    "latest": "https://zenodo.org/api/records/3864857"
  }, 
  "conceptdoi": "10.5281/zenodo.3864856", 
  "created": "2020-05-29T05:24:28.890389+00:00", 
  "updated": "2020-05-29T08:20:26.737419+00:00", 
  "conceptrecid": "3864856", 
  "revision": 2, 
  "id": 3864857, 
  "metadata": {
    "access_right_category": "success", 
    "doi": "10.5281/zenodo.3864857", 
    "description": "<p>Glycogen synthase kinase 3 (GSK-3) is a <a href=\"http://en.wikipedia.org/wiki/Serine/threonine_protein_kinase\">serine/threonine protein kinase</a> that mediates the addition of phosphate molecules onto <a href=\"http://en.wikipedia.org/wiki/Serine\">serine</a> and <a href=\"http://en.wikipedia.org/wiki/Threonine\">threonine</a> amino acid residues. First discovered in 1980 as a regulatory kinase for its namesake, <a href=\"http://en.wikipedia.org/wiki/Glycogen_synthase\">Glycogen synthase</a>, GSK-3 has since been identified as a kinase for over forty different proteins in a variety of different pathways. GSK-3 has recently been the subject of much research because it has been implicated in a number of diseases, including Type II diabetes (<a href=\"http://en.wikipedia.org/wiki/Diabetes_mellitus_type_2\">Diabetes mellitus type 2</a>), <a href=\"http://en.wikipedia.org/wiki/Alzheimer%27s_Disease\">Alzheimer&#39;s Disease</a>, <a href=\"http://en.wikipedia.org/wiki/Inflammation\">inflammation</a>, <a href=\"http://en.wikipedia.org/wiki/Cancer\">cancer</a>, and <a href=\"http://en.wikipedia.org/wiki/Bipolar_disorder\">bipolar disorder</a>. A plethora of GSK-3 inhibitors has been described and most of the effects were observed in vitro and cellular studies. Present study is aimed at design of GSK-3 Inhibitors, their molecular docking studies using online molecular docking software, i.e. www. Dockingserver.com. Based upon previous studies on 1, 3, 4-oxadiazoles as GSK-3 inhibitors, 1, 3, 4-oxadiazole molecule skeleton was taken as the core skeleton &amp; 4 different modifications were made. The compounds were docked with GSK (PDB ID: 3f88 and PDB ID: 4E7W).The results have shown appreciable molecular docking interactions with the GSK-3 protein amino acid residues. The Est. inhibition constant, Ki values for the ligands were observed in &micro;M values. . It is observed that Ligand I has shown Est. free energy of binding -10.17 which is said to be better than the other 3 ligands &amp; reference ligands.</p>", 
    "license": {
      "id": "CC-BY-4.0"
    }, 
    "title": "DESIGN & MOLECULAR DOCKING STUDIES OF COUMARIN SUBSTITUTED 1, 3, 4-OXADIAZOLES AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS.", 
    "relations": {
      "version": [
        {
          "count": 1, 
          "index": 0, 
          "parent": {
            "pid_type": "recid", 
            "pid_value": "3864856"
          }, 
          "is_last": true, 
          "last_child": {
            "pid_type": "recid", 
            "pid_value": "3864857"
          }
        }
      ]
    }, 
    "communities": [
      {
        "id": "iajpr"
      }
    ], 
    "keywords": [
      "GSK-3 Inhibitors, Coumarin Containing 1,3, 4-Oxadiazoles, Design & Molecular Docking."
    ], 
    "publication_date": "2020-05-29", 
    "creators": [
      {
        "affiliation": "S.E.T.'s College of Pharmacy, S. R. Nagar, Near Microwave Tower, Dharwad-580002.", 
        "name": "Purohit S.S.*, Kulkarni V.H., Joshi S.D."
      }
    ], 
    "access_right": "open", 
    "resource_type": {
      "subtype": "article", 
      "type": "publication", 
      "title": "Journal article"
    }, 
    "related_identifiers": [
      {
        "scheme": "doi", 
        "identifier": "10.5281/zenodo.3864856", 
        "relation": "isVersionOf"
      }
    ]
  }
}
50
24
views
downloads
All versions This version
Views 5050
Downloads 2424
Data volume 38.1 MB38.1 MB
Unique views 4141
Unique downloads 2222

Share

Cite as